Resectable pancreatic small cell carcinoma

Rare Tumors

Volumn 3, Issue 1, 2011, Pages 13-17

  Winter, Jordan M ^a   Narang, Amol K ^a   Mansfield, Aaron S ^b   Herman, Joseph M ^a   Cameron, John L ^a   Laheru, Dan ^a   Eckhauser, Fred E ^a   Olson, Mathew T ^a   Hruban, Ralph H ^a   Miller, Robert C ^b   Andersen, Dana K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Carcinoma; Pancreas; Resectable; Small cell

Indexed keywords

CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MITOMYCIN; OBATOCLAX; PACLITAXEL; TOPOTECAN;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; PANCREAS CARCINOMA; PANCREATIC SMALL CELL CARCINOMA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PROGNOSIS; SURVIVAL TIME; UNSPECIFIED SIDE EFFECT;

EID: 79952415112     PISSN: 20363605     EISSN: 20363613     Source Type: Journal    
DOI: 10.4081/rt.2011.e5     Document Type: Article

References (36)

1. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006; 10:1199-210; discussion 1210-1191.
2. Berkel S, Hummel F, Gaa J, et al. Poorly differentiated small cell carcinoma of the pancreas. A case report and review of the literature. Pancreatology 2004; 4:521-6.
3. Kajikawa M, Kondo K, Kataoka M, et al. [A case of endocrine cell carcinoma (small cell carcinoma) of duodenum]. Nippon Shokakibyo Gakkai Zasshi 2006; 103:523-8.
4. Kaiho T, Tanaka T, Tsuchiya S, et al. A case of small cell carcinoma of the common bile duct. Hepatogastroenterology 2005; 52:363-7.
5. Kuraoka K, Taniyama K, Fujitaka T, et al. Small cell carcinoma of the extrahepatic bile duct: case report and immunohisto chemical analysis. Pathol Int 2003; 53:887-91.
6. Arakura N, Muraki T, Komatsu K, et al. Small cell carcinoma of the extrahepatic bile duct diagnosed with EUS-FNA and effectively treated with chemoradiation. Intern Med 2008; 47:621-5.
7. Selvakumar E, Rajendran S, Balachandar TG, et al. Neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic evaluation. Hepatobiliary Pancreat Dis Int 2008; 7:422-5.
8. Hruban RH, Klimstra DS, Pitman MB. Tumors of the pancreas. Nomenclature for Pancreatic Neoplasia. 4th ed. Washington D.C.: Armed Forces Institute of Pathology; 2006.
9. Klimstra DS, Modlin IR, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 2010; 39:707-12.
10. Ichikawa T, Federle M P, Ohba S, et al. Atypical exocrine and endocrine pancreatic tumors (anaplastic, small cell, and giant cell types): CT and pathologic features in 14 patients. Abdom Imaging 2000; 25:409-19.
11. Wang RF, Chou YH, Hwang JI, et al. Primary small cell carcinoma of the pancreas with an unusual sonographic appearance. J Clin Ultrasound 2007; 35:82-4.
12. Chetty R, Clark S P, Pitson GA. Primary small cell carcinoma of the pancreas. Pathology 1993; 25:240-2.
13. Zamboni G, Franzin G, Bonetti F, et al. Small cell neuroendocrine carcinoma of the ampullary region: a clinicopathologic, immunohistochemical, and ultrastructural study of three cases. Am J Surg Pathol 1990; 14:703-13.
14. Addis BJ, Hamid Q, Ibrahim NB, et al. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumors of the lung. Journal of Pathology 1987; 153:137-50.
15. Lin X, Saad RS, Luckasevic RA, et al. Diagnostic value of CDX-2, and TTF-1expresssions in separating metastatic neuroendocrine neoplasms of unknown origin. Appl Immunohistochem Mol Morphol 2007; 15:407-14.
16. Agoff SN, Lamps LW, Philip AT, et al. Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroen-docrine tumors. Mod Pathol 2000; 13:238-42.
17. Beasley, MB. Immunohistochemistry of pulmonary and pleural Neoplasia. Arch Pathol Lab Med 2008; 132:1062-72.
18. Kauffman O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000; 36:415-20.
19. Li AF, Li AC, Hsu CY, et al. Small cell carcinomas in gastrointestinal tract: immuno-histochemical and clinicopathologic features. J Clin Pathol 2010; 63:620-5.
20. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000; 24:1217-1223.
21. Matsubayashi H, Fujiwara S, Kobayashi Y, et al. A small cell carcinoma of the pancreas with a high level of serum ProGRP. J Clin Gastroenterol 2004; 38:834-5.
22. Nakamura Y, Tajiri T, Uchida E, et al. Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas. J Hepatobiliary Pancreat Surg 2005; 12:93-8.
23. Hoefer M, Schmidt S, Welter J, et al. Diagnostic value of somatostatin receptor scintigraphy with indium-111 pentetreotide in small cell bronchial carcinoma. Pneumologie 1998; 52:106-12.
24. Chung MS, Ha TK, Lee KG, Paik SS. A case of long survival in poorly differentiated small cell carcinoma of the pancreas. World J Gastroenterol 2008; 14:4964-7.
25. Kinoshita K, Minami T, Ohmori Y, et al. Curative resection of a small cell carcinoma of the pancreas: report of a case of long survival without chemotherapy. J Gastroenterol Hepatol 2004; 19:1087-91.
26. Sakamoto H, Kitano M, Komaki T, et al. Small cell carcinoma of the pancreas: role of EUS-FNA and subsequent effective chemotherapy using carboplatin and etoposide. J Gastroenterol 2009; 44:432-28.
27. Yamagami Y, Ueshima S, Mizutani S, et al. [An autopsied case of giant small cell carcinoma of the pancreas]. Gan To Kagaku Ryoho 2009; 36:123-5.
28. Vos B, Awada A, Hendlisz A. Primary small cell carcinoma of the pancreas: An extensive review of the literature with an emphasis on therapy and prognosis. Cancer Therapy 2008; 6:857-64.
29. Ordonez NG, Cleary KR, Mackay B. Small cell undifferentiated carcinoma of the pancreas. Ultrastruct Pathol 1997; 21:467-74.
30. Morikawa T, Kobayashi S, Yamadori I, et al. Three cases of extrapulmonary small cell carcinoma occurring in the prostate, stomach, and pancreas. Indian J Cancer 1994; 31:268-73.
31. Eriksson B, Oberg K. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook. Ann Oncol 1999; 10:31-8.
32. Namieno T, Koito K, Nagakawa T, et al. Diagnostic features on images in primary small cell carcinoma of the pancreas. Am J Gastroenterol 1997; 92:319-22.
33. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas - 616 patients: Results, outcomes, and prognostic indicators. J Gastroinstest Surg 2000; 4:567-79.
34. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007; 297:267-77.
35. Regine, WF. Five year Results of the Phase III Intergroup Trial (RTOG 97-04) of Adjuvant Pre and Postchemoradiation (CRT) 5-FU vs. Gemcitabine (G) For Resected Pancreatic Adenocarcinoma: Implications for Future International Trial Design. Int J Radiat Oncol Biol Phys 2009; 75:S55-S5.
36. Hsu CC, Herman JM, Corsini MM, et al. Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Mayo collaborative study. Ann Surg Oncol 2010; 4:981-90.